CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Treatment of Relapsed ro Refractory Acute leukemia with High / Intermediate - dose Cytarabine and Idarubicin

Seong Chul Kim, Yoo Hong Min, Hyun Jin Noh, Seung Tae Lee, Bo Yong Chung, Jee Sook Hahn, Yun Woong Ko

Cancer Research and Treatment. 1996;28(2):301-308.

A phase I trial of a single high dose of idarubicin combined with high-dose cytarabine as induction therapy in relapsed or refractory adult patients with acute lymphoblastic leukemia

MA Weiss, P Drullinsky, P Maslak, D Scheinberg, DW Golde

Leukemia. 1998;12(6):865-868

Link1

Link2 Link3

Idarubicin in combination with intermediate-dose cytarabine in the treatment of refractory or relapsed acute leukemias*

Angelo M. Carella, Ester Pungolino, Gabriella Piatti, Eugenia Gaozza, Sandro Nati, Mauro Spriano, Domenico Giordano, Tiziana D'Amico, Eugenio Damasio

European Journal of Haematology. 2009;43(4):309-313

Link1 Link2

Idarubicin and high-dose cytarabine in the treatment of refractory and relapsed acute lymphoblastic leukemia

F. Giona, A.M. Testi, S. Amadori, G. Meloni, M. Carotenuto, L. Resegotti, R. Colella, P. Leoni, A.M. Carella, P. Grotto, R. Miniero, F. Mandelli

Annals of Oncology. 1990;1(1):51-55

Link1 Link2 Link3

High-dose cytarabine as salvage therapy for relapsed or refractory acute myeloid leukemia-is more better or more of the same?

Ofir Wolach, Gilad Itchaki, Michal Bar-Natan, Moshe Yeshurun, Ron Ram, Corina Herscovici, Ofer Shpilberg, Dan Douer, Martin S. Tallman, Pia Raanani

Hematological Oncology. 2015;34(1):28-35

Link1 Link2 Link3

Idarubicin plus attenuated high-dose cytosine arabinoside in the treatment of relapsed and refractory acute leukemia

L. Cavanna, M. Stasi, F. Fornari, G. Civardi, G. Sbolli, M. Moretto, L. Buscarini

European Journal of Haematology. 2009;45(3):180-181

Link1 Link2

Combination chemotherapy of intermediate-dose cytarabine, idarubicin, plus etoposide and subsequent mobilized donor leukocyte infusion for relapsed acute leukemia after allogeneic bone marrow transplantation

Je-Hwan Lee, Kyoo-Hyung Lee, Shin Kim, Miee Seol, Sang-Hee Kim, Woo-Kun Kim, Jung-Shin Lee

Leukemia Research. 2001;25(4):305-312

Link1 Link2

Salvage therapy of refractory and relapsed acute leukemia with high dose mitoxantrone and high dose cytarabine

Pia Raanani, Ofer Shpilberg, Shmuel Gillis, Abraham Avigdor, Izhar Hardan, Miriam Berkowicz, Orit Sofer, Izidore Lossos, Angela Chetrit, Dina Ben-Yehuda, Isaac Ben-Bassat

Leukemia Research. 1999;23(8):695-700

Link1 Link2

Letter to the Editor:FLAG (fludarabine, high-dose cytarabine and G-CSF) for refractory and high-risk relapsed acute leukemia in children

Nazan Sarper, Nevin Yalman

Medical and Pediatric Oncology. 2000;34(2):163-163

Link1 Link2

FLAG (fludarabine, high-dose cytarabine, and G-CSF) for refractory and high-risk relapsed acute leukemia in children

A.J. McCarthy, L.A. Pitcher, I.M. Hann, A. Oakhill

Medical and Pediatric Oncology. 1999;32(6):411-415

Link1 Link2

Clofarabine and Low-Dose Cytarabine Combination in Relapsed/Refractory Acute Myeloid Leukemia Patients with High Risk Features

Carlos Vigil, Nusrat Jahan, Oana Paun, Jennifer Weis, Kevin Heckman, Margarida Silverman, Thomas Carter

Clinical Lymphoma Myeloma and Leukemia. 2017;17:S297

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.